vimarsana.com
Home
Live Updates
First phase I trial of intravenous mistletoe extract to trea
First phase I trial of intravenous mistletoe extract to trea
First phase I trial of intravenous mistletoe extract to treat advanced cancer
Mistletoe extract has been widely used to support cancer therapy and improve quality of life, but there has been a lack of clinical trials and data to support its use.
Related Keywords
Lin Wang ,
Thomas Odeny ,
Jennifern Durham ,
Zhao Wang ,
Emily Henderson ,
Christianf Meyer ,
Nilofers Azad ,
Wei Fu ,
Helixor Heilmittel Gmb ,
Deborahk Armstrong ,
Rajedra Kumar ,
Channing Paller ,
Kavya Boyapati ,
Sushantk Kachhap ,
Luisa Diaz ,
Daniela Laheru ,
Julier Brahmer ,
Ilene Browner ,
Stephanie Gaillard ,
Cancer Research ,
Cancer Research Industry ,
Johns Hopkins Kimmel Cancer Center ,
National Institutes Of Health ,
Cancer Research Communications ,
Big Inc ,
Research Industry Focus ,
Homeopathic Pharmacopoeia ,
Ivelisse Page ,
National Institutes ,
Believe Big ,
Helixor Heilmittel ,
Cancer ,
Cancer Therapy ,
Cancer Treatment ,
Chemotherapy ,
Research ,